Article
Cell Biology
Xiaomin Xi, Jiting Wang, Yue Qin, Weidong Huang, Yilin You, Jicheng Zhan
Summary: MUC1 is highly expressed in breast cancer and its role in drug sensitivity is unclear. Knocking out MUC1 or inhibiting it enhances the sensitivity of breast cancer cells to drugs. Further investigation revealed that the extracellular glycosylation of MUC1 is crucial for membrane-dependent drug resistance. Targeting the glycosylation of MUC1 may promote drug sensitivity and efficacy.
CELL DEATH & DISEASE
(2022)
Review
Cell Biology
Yalan Dai, Xinyi Zhang, Yingjun Ou, Linglin Zou, Duoli Zhang, Qingfan Yang, Yi Qin, Xiuju Du, Wei Li, Zhanpeng Yuan, Zhangang Xiao, Qinglian Wen
Summary: Breast cancer has the highest global incidence among all tumor types and metastasis is a critical cause of poor prognosis. Anoikis, a form of apoptosis induced by cell detachment from the native environment, is a crucial process in tumor metastasis. Understanding the mechanisms of anoikis resistance can inform strategies for preventing and regressing metastatic breast cancer.
CELL COMMUNICATION AND SIGNALING
(2023)
Review
Biochemistry & Molecular Biology
Nami Yamashita, Donald Kufe
Summary: TNBC is an aggressive malignancy with limited treatment options and few insights into its druggable targets. MUC1-C has been identified as a crucial protein in TNBC CSCs, inducing EMT, epigenetic reprogramming, and chromatin remodeling. Targeting MUC1-C may lead to the elimination of TNBC CSCs and provide new treatment options for this difficult-to-treat cancer.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Oncology
Aysooda Hosseinzadeh, Faezeh Poursoleiman, Akram Naghdipour Biregani, Ahmad Esmailzadeh
Summary: Despite the complexity of cancer, natural flavonoids have shown potential as therapeutic agents by inhibiting metastasis and inducing cell death in cancer cells. This review discusses the dynamic relationship between metastasis, autophagy, anoikis, and the effects of flavonoids, suggesting that they can be effective in targeting both sensitive and resistant cancer cells.
CANCER CELL INTERNATIONAL
(2023)
Article
Cell Biology
Sandhya Chipurupalli, Peijia Jiang, Xiaoyang Liu, Julia Linhares Santos, Paola Marcato, Kirill V. Rosen
Summary: Drugs that induce iron-mediated cell death, known as ferroptosis, show promise for cancer treatment. In the study of breast cancer, the ferroptosis-inducing drug erastin was found to significantly inhibit tumor growth in mice, but only minimally reduce growth in 2D cell culture. However, when tested on 3D breast cancer cell cultures, erastin and sulfasalazine showed stronger inhibition. The mechanism behind this differential effect involves the upregulation of autophagy stimulators and heme oxygenase-1 (HO-1) in 2D culture cells compared to 3D culture cells.
CELL DEATH & DISEASE
(2023)
Article
Oncology
Radhika P. Gogoi, Sandra Galoforo, Alexandra Fox, Colton Morris, Harry Ramos, Vir K. Gogoi, Hussein Chehade, Nicholas K. Adzibolosu, Chenjun Shi, Jitao Zhang, Roslyn Tedja, Robert Morris, Ayesha B. Alvero, Gil Mor
Summary: The study identified CTGF as a crucial gene for maintaining the epithelial phenotype and inhibiting EMT. Its loss is associated with early cellular modifications required for EMT.
Article
Cell Biology
Yu-Jie Dong, Wei Feng, Yan Li
Summary: The study identified the HOTTIP-miR-205-ZEB2 axis as a key player in cisplatin resistance in ovarian cancer cells. Inhibiting HOTTIP and increasing miR-205 levels can reverse resistance to cisplatin, indicating that modulation of this axis may improve drug efficacy.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Oncology
Romana Dolinschek, Julia Hingerl, Anke Benge, Christian Zafiu, Elisabeth Schuren, Eva-Kathrin Ehmoser, Daniela Lossner, Ute Reuning
Summary: The study investigated the mechanisms of survival in ascitic ovarian cancer cells and found that a specific variant of the αvß3 integrin can affect tumor cell resistance to anoikis and cisplatin. This variant promotes activation of survival signaling pathways, inhibiting apoptosis and impacting peritoneal metastasis.
MOLECULAR ONCOLOGY
(2021)
Article
Multidisciplinary Sciences
Jianpin He, Abigail M. Abikoye, Brett P. McLaughlin, Ryan S. Middleton, Ryan Sheldon, Russell G. Jones, Zachary T. Schafer
Summary: Cancer cells that have detached from the extracellular matrix (ECM) are resistant to cell death induced by ferroptosis, a type of programmed cell death. The resistance is not caused by changes in membrane lipid content, but by alterations in iron metabolism, resulting in low levels of free iron. Lowering the levels of ferritin, a protein that stores iron, can sensitize ECM-detached cells to ferroptosis. This finding suggests that therapeutics targeting ferroptosis may be ineffective against cancer cells detached from the ECM.
Article
Biochemistry & Molecular Biology
Kentaro Kajiwara, Ping-Kuan Chen, Yuichi Abe, Satoru Okuda, Shunsuke Kon, Jun Adachi, Takeshi Tomonaga, Yasuyuki Fujita, Masato Okada
Summary: This study reveals a molecular mechanism for cell fate switching during epithelial cell competition. Src transformation promotes focal adhesion maturation and extracellular matrix degradation. Src-transformed cells undergo basal delamination within lipid rafts, while they are apically extruded when Src is outside of lipid rafts. This process is mediated by the activation of the Src-STAT3-MMP axis through lipid rafts, which requires the presence of CUB-domain-containing protein 1 (CDCP1). These findings contribute to our understanding of the mechanisms underlying cancer cell invasion.
Article
Cell Biology
Shouyang Song, Zhen Yu, Yajing You, Chenxi Liu, Xiaoyu Xie, Huanran Lv, Feng Xiao, Qiang Zhu, Chengyong Qin
Summary: This study confirms the crucial role of EGFR/MET in HCC, as they promote liver cancer metastasis by regulating signaling pathways and resisting immune attacks.
CELL DEATH & DISEASE
(2022)
Article
Oncology
Qi Lu, Li Wang, Yabiao Gao, Ping Zhu, Luying Li, Xue Wang, Youping Jin, Xiuling Zhi, Jerry Yu, Xin Li, Xingjun Qin, Ping Zhou
Summary: The study revealed that lncRNA APOC1P1-3 promotes breast cancer metastasis by regulating apoptosis and anoikis resistance-related protein expression. It acts as a sponge to block the inhibition of Bcl-2 by specifically binding to miRNA-188-3p.
CANCER CELL INTERNATIONAL
(2021)
Article
Biology
Rungroch Sungthong, Hnin Ei Ei Khine, Somruethai Sumkhemthong, Pithi Chanvorachote, Rossarin Tansawat, Chatchai Chaotham
Summary: This study found that prolonging the anchorage-free lifetime of non-small-cell lung cancer cells enhances their resistance to anoikis, promotes cell migration, and triggers metabolic reprogramming. Metabolomics analysis revealed significant changes in the levels of several metabolites associated with anoikis resistance. These findings provide insights into the mechanisms of anoikis resistance in lung cancer cells and offer potential biomarkers for early diagnosis.
BIOLOGICAL RESEARCH
(2023)
Review
Oncology
Funmilayo O. Adeshakin, Adeleye O. Adeshakin, Lukman O. Afolabi, Dehong Yan, Guizhong Zhang, Xiaochun Wan
Summary: Cancer cells develop mechanisms to resist anoikis, promoting invasion and metastasis. Understanding the mechanisms driving anoikis resistance is crucial for preventing tumor progression and metastasis, with metabolic pathways playing a key role in helping cells evade anoikis.
FRONTIERS IN ONCOLOGY
(2021)
Review
Cell Biology
Farzad Sattari Fard, Nazila Jalilzadeh, Amir Mehdizadeh, Fakhrosadat Sajjadian, Kobra Velaei
Summary: The development of effective cancer treatments requires a detailed understanding of cellular mechanisms involved in cancer progression and metastasis. Anoikis, a special type of apoptosis induced by loss of anchorage, is a driving mechanism in cancer metastasis. This review discusses the mechanisms of gaining anoikis/anoikis resistance phenotype in tumor cells and highlights the significance of anoikis in malignancies for cancer diagnosis and therapy development.
CELL BIOLOGY INTERNATIONAL
(2023)
Article
Gastroenterology & Hepatology
John Hilkens, Nikki C. Timmer, Mandy Boer, Gerjon J. Ikink, Matthias Schewe, Andrea Sacchetti, Martijn A. J. Koppens, Ji-Ying Song, Elvira R. M. Bakker
Article
Multidisciplinary Sciences
Gerjon J. Ikink, Mandy Boer, Elvira R. M. Bakker, John Hilkens
NATURE COMMUNICATIONS
(2016)
Article
Biochemistry & Molecular Biology
Gerjon J. Ikink, Mandy Boer, Elvira R. M. Bakker, Annabel Vendel-Zwaagstra, Chris Klijn, Jelle ten Hoeve, Jos Jonkers, Lodewyk F. Wessels, John Hilkens
Article
Oncology
Qicheng Zhao, Xiuli Guo, Gerard B. Nash, Philip C. Stone, John Hilkens, Jonathan M. Rhodes, Lu-Gang Yu
Article
Oncology
Severine Van Slambrouck, John Hilkens, Marco Bisoffi, Wim F. A. Steelant
INTERNATIONAL JOURNAL OF ONCOLOGY
(2009)
Article
Biochemistry & Molecular Biology
Qicheng Zhao, Monica Barclay, John Hilkens, Xiuli Guo, Hannah Barrow, Jonathan M. Rhodes, Lu-Gang Yu
Article
Multidisciplinary Sciences
Christiaan Klijn, Marco J. Koudijs, Jaap Kool, Jelle ten Hoeve, Mandy Boer, Joost de Moes, Waseem Akhtar, Martine van Miltenburg, Annabel Vendel-Zwaagstra, Marcel J. T. Reinders, David J. Adams, Maarten van Lohuizen, John Hilkens, Lodewyk F. A. Wessels, Jos Jonkers
Article
Multidisciplinary Sciences
Michael Chalick, Oded Jacobi, Edward Pichinuk, Christian Garbar, Armand Bensussan, Alan Meeker, Ravit Ziv, Tania Zehavi, Nechama I. Smorodinsky, John Hilkens, Franz-Georg Hanisch, Daniel B. Rubinstein, Daniel H. Wreschner
Article
Genetics & Heredity
Johann de Jong, Waseem Akhtar, Jitendra Badhai, Alistair G. Rust, Roland Rad, John Hilkens, Anton Berns, Maarten van Lohuizen, Lodewyk F. A. Wessels, Jeroen de Ridder
Article
Biochemistry & Molecular Biology
Tushar Piyush, Anisha R. Chacko, Paulina Sindrewicz, John Hilkens, Jonathan M. Rhodes, Lu-Gang Yu
CELL DEATH AND DIFFERENTIATION
(2017)
Article
Oncology
Gerjon J. Ikink, John Hilkens
MOLECULAR & CELLULAR ONCOLOGY
(2017)
Article
Genetics & Heredity
Vassiliki Theodorou, Melanie A. Kimm, Mandy Boer, Lodewyk Wessels, Wendy Theelen, Jos Jonkers, John Hilkens
Article
Biochemistry & Molecular Biology
Lu-Gang Yu, Nigel Andrews, Qicheng Zhao, Daniel McKean, Jennifer F. Williams, Lucy J. Connor, Oleg V. Gerasimenko, John Hilkens, Jun Hirabayashi, Kenichi Kasai, Jonathan M. Rhodes
JOURNAL OF BIOLOGICAL CHEMISTRY
(2007)
Article
Oncology
Severine Van Slambrouck, John Hilkens, Wim F. A. Steelant